Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Lymphopenia 1Esophageal Neoplasms 1

Interventions

Fluorouracil 14Paclitaxel 13Oxaliplatin 13pembrolizumab 12Leucovorin 10Carboplatin 9Capecitabine 8Trastuzumab 7Radiotherapy 7Nivolumab 7Drug Therapy 7Cisplatin 7Radiation 6Esophagectomy 6Taxes 5Specimen Handling 5Surgical Procedures, Operative 4Irinotecan 4trastuzumab deruxtecan 3tislelizumab 3patritumab deruxtecan 3Radiotherapy, Intensity-Modulated 3Proton Therapy 3Immunotherapy 3Blood Specimen Collection 3zanidatamab 2ulixertinib 2trastuzumab biosimilar HLX02 2relatlimab 2durvalumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Esophageal Neoplasms × SARS-CoV-2 inactivated vaccines × 90 days × Clear all
NCT06181656 2026-05-20

Serologic Response to Pneumococcal Vaccination Among Esophageal Cancer Patients With High Grade Lymphopenia After Chemoradiation

M.D. Anderson Cancer Center

Recruiting
80 enrolled
Gastrointestinal

Esophageal Neoplasms, Lymphopenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡